CVS Health Plans to Split Into Two Companies

Direct answer

CVS Health plans to break itself into two separate public companies. One company will run pharmacies, and the other will run health insurance and pharmacy benefits. Reuters reported the plan on November 3, 2026, citing the Wall Street Journal, which quoted CVS chief executive David Joyner. The Financial Times had reported the plan earlier the same day.

What happened

CVS Health is a large United States health company worth about $117 billion, with about 9,000 retail pharmacies. It bought the pharmacy benefits manager Caremark nearly 20 years ago, and it bought the insurer Aetna for $78 billion nearly a decade ago. The idea at the time was that joining pharmacies, drug benefits, and insurance in one company could help save on health costs.

Under the reported plan, that structure would be undone. One company would keep the CVS Health name and be run by Joyner. It would hold Aetna insurance, the Caremark pharmacy benefits business, Oak Street Health primary care clinics, Signify Health home health visits, and the specialty drug business. The second company would be called CVS Pharmacy. It would include mail order pharmacy, retail drugstores, and the MinuteClinic chain. Both companies would be publicly traded, so investors could own shares in each one separately.

CVS had explored a possible breakup in 2024, when its insurance business was struggling. Joyner took over as chief executive in October 2024 after Karen Lynch left the role. Reuters reported that CVS did not respond to its request for comment, and that shares were up 0.1 percent in extended trading after the report.

Why it matters for beginners

A pharmacy benefits manager, often shortened to PBM, is a middleman in the drug supply chain. It helps decide which medicines are covered, negotiates prices, and processes prescriptions for insurers, employers, and government programs. When one company owns pharmacies, a PBM, and an insurer at the same time, critics say it can create conflicts of interest and give the company too much influence over drug prices.

That is why this story matters beyond one company. Lawmakers and regulators have been pressing large health companies to be clearer about how they price services and profit from linked businesses. The Federal Trade Commission settled a case with CVS this summer that restricts how Caremark does business with other pharmacies. Joyner told the Wall Street Journal that regulatory issues were not driving the decision, but the split could still ease some concerns at state level about joint ownership of a PBM and retail drugstores.

For ordinary customers, a split does not by itself change a prescription price tomorrow. It does change how the business is run and watched. A standalone pharmacy company would have to stand on its own sales, while the insurance and benefits company would have to stand on its own health costs. Analysts quoted by Reuters said separate companies could be valued more highly than the combined company, and that shareholders would be expected to keep stakes in both new companies.

What to watch next

CVS was set to report its third quarter 2026 results on November 4, 2026, which may give more detail on the plan and its timing. Watch for a formal company statement, a timetable, and any detail on how shares, costs, and customer services would be divided. Also watch for reaction from regulators and state officials, since pharmacy and insurance rules vary by state.

FAQ

What is CVS splitting into?

CVS plans to split into two public companies: one holding insurance, pharmacy benefits, and related health services under the CVS Health name, and one called CVS Pharmacy holding retail drugstores, mail order pharmacy, and MinuteClinic.

Why is CVS doing this now?

Joyner said the businesses are best served by splitting, in the view reported by the Wall Street Journal. The plan follows earlier struggles in the insurance business, rising medical costs, and growing scrutiny of large integrated health companies.

Will my pharmacy or insurance change straight away?

No change was announced for customers in the report. A split of this size would take time to complete, and the two businesses would keep some commercial agreements with each other, according to the report.

Does a split mean lower drug prices?

Not necessarily. A split changes company structure, not drug prices directly. Prices depend on many factors, including drug makers, insurers, pharmacies, and government rules.